Table 2 Treatment during hospitalization
Variable | Serum glucose level on admission | ||||
|---|---|---|---|---|---|
<7.8 mmol/l | 7.8 to 10.9 mmol/l | 11.0 to 16.5 mmol/l | ≥16.6 mmol/l | P value | |
(group 1, n= 181) | (group 2, n= 215) | (group 3, n= 216) | (group 4, n= 204) | ||
Primary PCI | 138 (76.2) | 177 (82.3) | 167 (77.3) | 162 (79.4) | 0.450 |
Facilitated PCI | 6 (3.3) | 3 (1.4) | 3 (1.4) | 2 (1.0) | 0.380 |
Thrombolysis | 11 (6.1) | 8 (3.7) | 9 (4.2) | 6 (2.9) | 0.470 |
Medical treatment | 26 (14.4) | 27 (12.6) | 37 (17.1) | 34 (16.7) | 0.527 |
Aspirin | 175 (96.7) | 203 (94.4) | 205 (94.9) | 177 (86.8) | <0.001 |
Clopidogrel | 173 (95.6) | 205 (95.3) | 200 (92.6) | 176 (86.3) | 0.001 |
Low molecular weight heparin | 48 (26.5) | 56 (26.0) | 53 (24.5) | 47 (23.0) | 0.852 |
Glycoprotein IIb/IIIa inhibitor | 23 (12.7) | 32 (14.9) | 42 (19.4) | 42 (20.6) | 0.121 |
Beta-blockers | 96 (53.0) | 123 (57.2) | 100 (46.3) | 104 (51.0) | 0.151 |
ACE inhibitors | 92 (50.8) | 107 (49.8) | 101 (46.8) | 95 (46.6) | 0.778 |
Angiotensin receptor blocker | 27 (14.9) | 31 (14.4) | 27 (12.5) | 28 (13.7) | 0.905 |
Statins | 119 (65.7) | 136 (63.3) | 118 (54.6) | 107 (52.5) | 0.016 |
Mechanical ventilation | 48 (26.5) | 49 (22.8) | 86 (39.8) | 85 (41.7) | <0.001 |
Intra-aortic balloon pump | 38 (21.0) | 46 (21.4) | 66 (30.6) | 63 (30.9) | 0.023 |
Defibrillator/cardioversion | 32 (17.7) | 38 (17.7) | 46 (21.3) | 50 (24.5) | 0.257 |
Temporary pacemaker | 22 (12.2) | 33 (15.3) | 42 (19.4) | 40 (19.6) | 0.148 |